J&J earnings beat estimates thanks to...

J&J earnings beat estimates thanks to new drugs, medical devices

There are 2 comments on the The Jersey Journal story from Oct 16, 2012, titled J&J earnings beat estimates thanks to new drugs, medical devices. In it, The Jersey Journal reports that:

Johnson & Johnson, the world's biggest maker of health-care products, beat analysts' earnings estimates in the third quarter by 3 cents on demand for medical tools acquired with the Synthes purchase and new prescription drugs.

Join the discussion below, or Read more at The Jersey Journal.


San Jose, CA

#3 Jan 4, 2013
It is high time that they provide compensation to people who have experienced the ill-effects of their products including those that incurred serious injuries from their mesh devices. There is comprehensive information at http://www.bladderslingrecall.us about issues surrounding mesh and bladder slings from J&J and other device makers. It may be of great benefit to those concerned and interested.

Brooklyn, NY

#4 Feb 16, 2013
J&J has been a major player in the healthcare and medical device industry. However, I read from this site bladdermeshlawsuit.us/what-mak es-transvaginal-mesh-dangerous / that they have been faced with legal troubles due to some mishaps with their mesh devices. It is also possible that they may also be facing legal challenges related to other products that they have. It may be difficult for the company to earn the trust of consumers again.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News Mannatech sues Las Vegas company in patent dispute (Apr '06) 16 hr Kevin 217
News Despite $19 million salary, Mylan CEO failed to... (Sep '16) Mar 13 Seniors For Fairness 4
News Regeneron Pharmaceuticals Inc (REGN) Given Aver... Mar 12 Ralph Petrillo 1
News Bashful? Buy the little blue pill online (May '13) Mar 4 Josel 15
News Sanofi : FDA to review Dupixent (dupilumab) as ... Mar 2 Ralph Petrillo 1
News Merck beats 1Q profit views with tight cost con... (May '16) Feb 24 American People W... 3
News Berkshire buys Teva, feels IBM blues as Apple b... Feb '18 follow the money 1